Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Bristol-Myers Squibb’s Opdivo Secures Two New Approvals for Esophageal Cancer in China

January 24, 2025
CompanyDrug

Henlius’ PD-1 Inhibitor HanSiZhuang Approved for First-Line SCLC Indication

January 24, 2025
CompanyMedical Device

Agilis Robotics Completes Successful Animal Testing for Surgical Robot

January 24, 2025
CompanyDeals

CARsgen and Huadong Medicine Partner to Commercialize BCMA CAR-T Product CT053 in China

January 24, 2025
CompanyDeals

Tongshu Gene Partners with LC Gene to Distribute Gene Mutation Detection Kit in China

January 24, 2025
CompanyDrug

3D Medicines’ 3D185 Receives Orphan Drug Designation for Gastric Cancer

January 24, 2025
CompanyDrug

Ascletis Pharma Initiates Dosing in Phase I Trial for COVID-19 Treatment ASC11

January 24, 2025
CompanyDeals

Base Therapeutics Secures Series A1 Funding to Advance Gene Editing Pipelines

January 24, 2025
CompanyDeals

ConceMed Raises Pre-Series A Funding to Expand Digestive Endoscope Pipeline

July 8, 2025
CompanyDrug

Luye Pharma’s Rykindo Receives FDA Approval for Schizophrenia and Bipolar I Disorder

January 24, 2025
Company

WuXi Biologics CEO Outlines Growth Amid Global Challenges at J.P. Morgan Conference

January 24, 2025
CompanyDrug

Hengrui’s Generic Cyclophosphamide Capsules Approved by China’s NMPA

January 28, 2025
1 2 … 6 7 8 9 10 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up